These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 20607219)
1. The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat. Jones CA; Brown AM; Auer DP; Fone KC Psychopharmacology (Berl); 2011 Mar; 214(1):269-83. PubMed ID: 20607219 [TBL] [Abstract][Full Text] [Related]
2. The atypical antipsychotic risperidone reverses the recognition memory deficits induced by post-weaning social isolation in rats. McIntosh AL; Ballard TM; Steward LJ; Moran PM; Fone KC Psychopharmacology (Berl); 2013 Jul; 228(1):31-42. PubMed ID: 23397053 [TBL] [Abstract][Full Text] [Related]
3. The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity. Woolley ML; Pemberton DJ; Bate S; Corti C; Jones DN Psychopharmacology (Berl); 2008 Feb; 196(3):431-40. PubMed ID: 18057917 [TBL] [Abstract][Full Text] [Related]
4. mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia. Engel M; Snikeris P; Matosin N; Newell KA; Huang XF; Frank E Psychopharmacology (Berl); 2016 Apr; 233(8):1349-59. PubMed ID: 26861891 [TBL] [Abstract][Full Text] [Related]
5. The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats. Pitsikas N; Markou A Neuropharmacology; 2014 Oct; 85():27-35. PubMed ID: 24859609 [TBL] [Abstract][Full Text] [Related]
6. The reversal of cognitive, but not negative or positive symptoms of schizophrenia, by the mGlu₂/₃ receptor agonist, LY379268, is 5-HT₁A dependent. Wierońska JM; Sławińska A; Stachowicz K; Łasoń-Tyburkiewicz M; Gruca P; Papp M; Pilc A Behav Brain Res; 2013 Nov; 256():298-304. PubMed ID: 23948211 [TBL] [Abstract][Full Text] [Related]
7. Neonatal phencyclidine administration and post-weaning social isolation as a dual-hit model of 'schizophrenia-like' behaviour in the rat. Gaskin PL; Alexander SP; Fone KC Psychopharmacology (Berl); 2014 Jun; 231(12):2533-45. PubMed ID: 24402141 [TBL] [Abstract][Full Text] [Related]
8. Blockade of dopamine D₃ but not D₂ receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment. Watson DJ; Marsden CA; Millan MJ; Fone KC Int J Neuropsychopharmacol; 2012 May; 15(4):471-84. PubMed ID: 21414250 [TBL] [Abstract][Full Text] [Related]
9. Down-Regulation of Hippocampal Genes Regulating Dopaminergic, GABAergic, and Glutamatergic Function Following Combined Neonatal Phencyclidine and Post-Weaning Social Isolation of Rats as a Neurodevelopmental Model for Schizophrenia. Gaskin PL; Toledo-Rodriguez M; Alexander SP; Fone KC Int J Neuropsychopharmacol; 2016 Nov; 19(11):. PubMed ID: 27382048 [TBL] [Abstract][Full Text] [Related]
10. Effects of the mGluR2/3 agonist LY379268 on ketamine-evoked behaviours and neurochemical changes in the dentate gyrus of the rat. Imre G; Salomons A; Jongsma M; Fokkema DS; Den Boer JA; Ter Horst GJ Pharmacol Biochem Behav; 2006 Jul; 84(3):392-9. PubMed ID: 16857251 [TBL] [Abstract][Full Text] [Related]
11. The effect of ((-)-2-oxa-4-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY379268), an mGlu2/3 receptor agonist, on EEG power spectra and coherence in ketamine model of psychosis. Fujáková M; Páleníček T; Brunovský M; Gorman I; Tylš F; Kubešová A; Řípová D; Krajča V; Horáček J Pharmacol Biochem Behav; 2014 Jul; 122():212-21. PubMed ID: 24631484 [TBL] [Abstract][Full Text] [Related]
12. Altered object exploration but not temporal order memory retrieval in an object recognition test following treatment of rats with the group II metabotropic glutamate receptor agonist LY379268. Lins BR; Ballendine SA; Howland JG Neurosci Lett; 2014 Feb; 560():41-5. PubMed ID: 24361135 [TBL] [Abstract][Full Text] [Related]
13. Characterization of Behavioral, Signaling and Cytokine Alterations in a Rat Neurodevelopmental Model for Schizophrenia, and Their Reversal by the 5-HT Shortall SE; Negm OH; Fowler M; Fairclough LC; Tighe PJ; Wigmore PM; King MV Mol Neurobiol; 2018 Sep; 55(9):7413-7430. PubMed ID: 29423817 [TBL] [Abstract][Full Text] [Related]
15. Environmental enrichment and a selective metabotropic glutamate receptor Garcia EJ; Cain ME Pharmacol Biochem Behav; 2020 May; 192():172907. PubMed ID: 32179027 [TBL] [Abstract][Full Text] [Related]
16. Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine. Cartmell J; Monn JA; Schoepp DD Psychopharmacology (Berl); 2000 Mar; 148(4):423-9. PubMed ID: 10928316 [TBL] [Abstract][Full Text] [Related]
17. The selective metabotropic glutamate 2/3 receptor agonist MGS0028 reverses isolation rearing-induced abnormal behaviors in mice. Ago Y; Araki R; Yano K; Kawasaki T; Chaki S; Nakazato A; Onoe H; Hashimoto H; Baba A; Takuma K; Matsuda T J Pharmacol Sci; 2012; 118(2):295-8. PubMed ID: 22293290 [TBL] [Abstract][Full Text] [Related]
18. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity. Galici R; Echemendia NG; Rodriguez AL; Conn PJ J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306 [TBL] [Abstract][Full Text] [Related]
19. The mGluR2/3 agonist LY379268 blocks the effects of GLT-1 upregulation on prepulse inhibition of the startle reflex in adult rats. Bellesi M; Conti F Neuropsychopharmacology; 2010 May; 35(6):1253-60. PubMed ID: 20072121 [TBL] [Abstract][Full Text] [Related]
20. Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats. Horiguchi M; Huang M; Meltzer HY Psychopharmacology (Berl); 2011 Sep; 217(1):13-24. PubMed ID: 21432027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]